Investor's Business Daily on MSN
Nektar posted promising alopecia results. Here's why it took a 20%-plus hit.
Nektar Therapeutics stock took a hit Thursday despite test results that suggested its drug has long-term benefits for ...
Nektar Therapeutics (NASDAQ:NKTR) presented new clinical and biomarker findings for rezpegaldesleukin, or REZPEG, at the EADV 2026 Congress, highlighting six-month off-treatment results in severe to ...
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, together with its ...
Rezpegaldesleukindemonstrateddurabilityanddeepeningofresponsethroughone year of treatment in two dermatological indications, reinforcing the ...
Thursday, Sun Pharmaceutical Industries Limited (SUNPHARMA) reported two-year safety and efficacy data for LEQSELVI (deuruxolitinib) in adults with severe alopecia areata at the 2026 European Academy ...
The FDA approved an expanded indication for baricitinib, a once daily oral JAK inhibitor, for teens aged 12 and older with ...
In cases of significant hair loss, wigs or hairpieces can be a practical solutioniStock Alopecia is a medical condition that results in hair loss, either in patches or over the entire scalp and body.
Speaking about her condition for the first time since the Oscars, Pinkett Smith dedicated an episode of Red Table Talk to the sufferers of alopecia and their families Julie Mazziotta is the Senior ...
Madeline Lee, who has been treated at NYU Langone for her alopecia areata, uses her creative talents to educate others and ...
Q32 Bio said it plans to advance bempikibart into a registration-directed development program for severe and very severe alopecia areata in the first half of 2027, subject to regulatory discussions.
Almost a month ago, WWE NXT Superstar and former champion Thea Hail opened up about her battle with alopecia. Hail had shared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results